Phase III, multicentre, randomised, double-blind, placebo-controlled, 104-week study of subcutaneous belimumab administered in combination with rituximab in adults with systemic lupus erythematosus (SLE): BLISS-BELIEVE study protocol
| Image |  |
|---|---|
| Description | scientific article published on 20 March 2019 |
| Author/s |
author: Betty Diamond David S Gordon |
| Publication date | March 20, 2019 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |